Bafna Pharmaceuticals share news, announcements and annual reports
NSE: BAFNAPHBSE: 532989Pharmaceuticals & BiotechnologySmall Cap
Bafna Pharmaceuticals Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 2008 on BSE, Aug 2013 on NSE
Last close ₹447.90down ₹9.10 (1.99%)BSE ₹447.90
Share price at the NSE close on 30 Oct 2026. Previous close ₹457.00.
30 Oct: open ₹457.00, high ₹457.00, low ₹447.90
52-week range of traded prices to 30 Oct 2026
₹94.77Low, 16 Mar 2026₹479.95High, 21 Oct 2026
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,060 Cr2,105th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 136.09
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 11.02
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 8.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 4.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.39
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 7,963
Bafna Pharmaceuticals routine notices
72 filed, newest first. Page 2 of 2.
Mar 2022
Jan 2022
Sep 2017
16 Sep · Routine
Nov 2016
Aug 2016
1 Aug · Routine
Meeting of the Board of Directors of the Company is scheduled on August 11, 2016, inter alia, to consider, the Unaudited Financial Results ....
Jun 2016
May 2016
18 May · Routine
Meeting of the Board of Doctors of the Company is scheduled on May 30, 2016, to consider among other things, the Audited Financial Results ....
Jan 2016
28 Jan · Routine
Meeting of the Board of Directors of the Company is scheduled on February 11, 2016, to consider and approve the Unaudited Financial Results ....
Oct 2015
23 Oct · Routine
Meeting of the Board of Directors of the Company is scheduled on November 06, 2015, inter alia, to consider the Un-Audited Financial ....
Jul 2015
28 Jul · Routine
Meeting of the Board of Directors of the Company is Scheduled to be held on August 12, 2015, inter alia, to consider the Unaudited Financial ....
May 2015
14 May · Routine
Meeting of the Board of Directors of the Company is scheduled to be held on May 29, 2015, inter alia, to consider the audited financial ....
Feb 2015
2 Feb · Routine
Trading window for dealing with securities of the Company will be closed for the employees & Directors w.e.f. February 02, 2015 to till ....
Nov 2014
4 Nov · Routine
Meeting of the Board of Directors of the Company is scheduled on November 07, 2014, inter alia, to consider the Un-Audited Financial ....
Oct 2014
30 Oct · Routine
Trading window for dealing with securities of the Company will be closed for the employees & Directors w.e.f. October 27, 2014 till the date of Board Meeting (both days inclusive).
Mar 2014
28 Mar · Routine
Trading window for dealing with securities of the Company will be closed for the employees & Directors w.e.f. March 27, 2014 till the ....
Jan 2014
2 Jan · Routine
Trading window for dealing with securities of the Company will be closed for the employees & Directors w.e.f. January 01, 2014 till date ....